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Abstract
Background: Exposure of adherent cells to DNA damaging agents, such as the bacterial cytolethal distending toxin (CDT) or
ionizing radiations (IR), activates the small GTPase RhoA, which promotes the formation of actin stress fibers and delays cell
death. The signalling intermediates that regulate RhoA activation and promote cell survival are unknown.
Principal Findings: We demonstrate that the nuclear RhoA-specific Guanine nucleotide Exchange Factor (GEF) Net1
becomes dephosphorylated at a critical inhibitory site in cells exposed to CDT or IR. Expression of a dominant negative Net1
or Net1 knock down by iRNA prevented RhoA activation, inhibited the formation of stress fibers, and enhanced cell death,
indicating that Net1 activation is required for this RhoA-mediated responses to genotoxic stress. The Net1 and RhoA-
dependent signals involved activation of the Mitogen-Activated Protein Kinase p38 and its downstream target MAPK-
activated protein kinase 2.
Significance: Our data highlight the importance of Net1 in controlling RhoA and p38 MAPK mediated cell survival in cells
exposed to DNA damaging agents and illustrate a molecular pathway whereby chronic exposure to a bacterial toxin may
promote genomic instability.
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Introduction
Cytolethal distending toxins (CDTs), produced by several
pathogenic Gram-negative bacteria, are protein toxins which
cause DNA damage (reviewed in [1]). The active holotoxin is a
tripartite complex [2,3], formed by the CdtA, CdtB and CdtC
subunits, (reviewed in [1]). Cellular intoxication with CDT induces
DNA double strand breaks and activation of checkpoint responses
that, depending on the cell type, lead to arrest in the G1 or G2
phases of the cell cycle [4–6]. These effects are similar to those
caused by ionizing radiation (IR), which is a well-characterized
DNA-damaging agent. Activation of the DNA damage responses
by CDT is consistent with the functional and structural homology
of the CdtB subunit with mammalian DNase I [7–9].
In adherent cells, CDT intoxication and exposure to IR are
associated with the formation of actin stress fibers, via activation of
the small GTPase RhoA [6]. While a large amount of data is
available regarding the activation of RhoA upon stimulation of
plasma membrane-bound receptors [10], the molecular mecha-
nisms regulating RhoA activation in response to these and other
DNA-damaging agents are still unknown. It is noteworthy that,
since RhoA activation occurs in the cytosol, the signals that
regulate its activation in response to DNA damage must be then
transduced from the nucleus.
Guanine nucleotide exchange factors (GEFs) are key activators
of the small GTPases that regulate the switch between the inactive
GDP-bound and the active GTP-bound forms of the GTPase
(reviewed in [11]). The vast majority of the known RhoA-specific
GEFs exhibit a cytoplasmic localization. One remarkable
exception is the RhoA-specific GEF encoded by the neuroepithe-
lioma transforming gene 1 (Net1) that is normally found in the
nucleus of mammalian cells (reviewed in [11]). Net1 was originally
isolated in a tissue culture screen for transforming genes in NIH
3T3 cell focus formation assays [12]. The oncogenic form of Net1
isolated from this screen lacked the first 145 amino acids. A
deletion mutant of Net1 lacking the first 121 amino acids was
shown to be constitutively active and induced: i) formation of actin
stress fibers; ii) activation of the Mitogen-Activated Protein Kinase
(MAPK) JNK; and iii) activation of the serum response factor
(SRF) [13,14].
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The regulation of Net1 activity is poorly understood. PAK1-
dependent phosphorylation of Net1 on Ser152 and Ser153 inhibits
its GEF activity and abolishes Net1-dependent RhoA activation and
stress fiber induction [15]. In addition, translocation of Net1 from
the nucleus to the cytoplasm is required for activation of RhoA. The
amino-terminus of Net1 contains multiple nuclear localization
signals, and deletion of this domain is associated with accumulation
of a constitutively active Net1 in the cytoplasm [14]. Taken together
these data suggest that the activation of Net1 requires both changes
in the phosphorylation pattern of specific inhibitory sites and
shuttling between the nucleus and the cytoplasm, but the signals that
trigger these events are still unknown.
In the present study, we have identified DNA damage as a
trigger for Net1 activation. We show that inhibition of Net1
prevents RhoA activation and stress fiber formation, and promotes
cell death upon intoxication or irradiation. We also demonstrate
that the Net1/RhoA dependent signals converges on the
activation of p38 MAPK and its downstream target MK2,
indicating that RhoA plays an important role in controlling the
activation of this MAPK pathway in response to genotoxic agents.
Results
DNA damage induces Net1 activation
We have previously shown that exposure to DNA damaging
agents induces activation of the small GTPase RhoA, which delays
cell death [6]. In order to investigate how the signal delivered by
DNA damage is transduced from the nucleus to the cytosol, we
have studied the activation of the RhoA specific GEF Net1 in
response to CDT or IR. These genotoxic agents were chosen since
they both induce DNA double strand breaks and activate identical
DNA damage checkpoint responses in mammalian cells [4–6].
Decreased phosphorylation of Net1 on the key negative regulatory
site Ser152 was used as the hallmark of Net1 activation [15].
Endogenous Net1 was immunoprecipitated from HeLa cells left
untreated or exposed to CDT for 12h, and the levels of Ser152
phosphorylation were assessed by western blot using a phospho-
specific antibody. As shown in Figure 1A, the phosphorylation of
endogenous Net1 on Ser152 (pS152-Net1) was significantly
decreased in intoxicated cells. To assess whether dephosphoryla-
tion of Net1 is a reproducible effect of DNA damage, HeLa cells
were transfected with a plasmid expressing an HA-epitope-tagged
Net1A, the major Net1 isoform expressed in these cells [16]. The
transfected cells were then exposed to CDT or IR and the
expression of total and phosphorylated Net1 was monitored over
time. A 70% decrease in the levels of pS152-Net1A was observed
within 30 min after irradiation. The effect was similar to that
achieved by CDT intoxication where low levels of p152-Net1A
were maintained for at least 12h (Figure 1B and data not shown).
Thus, exposure to DNA damage induces dephosphorylation of
Net1 on its negative regulatory site.
Net1 is required for activation of RhoA and remodelling
of the actin cytoskeleton in response to DNA damage
To assess whether Net1 is required for activation of RhoA, the
expression of endogenous Net1 was knocked down by RNAi prior
to intoxication or irradiation. Transfection with a short hairpin
loop interfering RNA expressing plasmid or siRNA oligonucleo-
tides were used to inhibit Net1 expression. Transfection of cells
with Net1 specific shRNA resulted in 90% reduction of the
endogenous Net1 96h after transfection (Figure 2A), while
transfection with a specific siRNA resulted in 60 to 70 percent
reduction 72h after transfection (Figure 2B). Since the effects of
Net1 specific shRNA or siRNA were reproducibly similar, the
results of Net1 knock down experiments have been summarized
together and are henceforth indicated as iRNA. Consistent with
our previous results [6], a 2- to 4-fold increase in the levels of
GTP-bound RhoA was observed in irradiated or intoxicated HeLa
cells as compared to the untreated controls. Knock down of
endogenous Net1 blocked the activation of RhoA in response to
IR or CDT (Figure 2C). Similar results were obtained in cells
expressing the dominant negative Net1DDH (data not shown).
This effect was not due to a general impairment of RhoA-
dependent responses since Net1 knock down did not prevent
RhoA activation or the formation of actin stress fibers in cells
treated with cytotoxic necrotizing factor 1 (CNF1) that constitu-
tively activates RhoA by deamidating Gln-63 and preventing
hydrolysis of bound GTP (Figures 2C and 2D).
We next examined whether blockade of Net1 affected the
RhoA-dependent formation of actin stress fibers in HeLa cells
exposed to CDT. Induction of stress fibers was detected upon
intoxication in approximately 80% of control non-transfected cells
Figure 1. Decreased phosphorylation of Net1 upon induction
of DNA damage. A) HeLa cells were left untreated or treated with
CDT (2 mg ml21) for 12h. The endogenous Net1 protein was
immunoprecipitated using a goat a-Net1 antibody, and samples were
analyzed by western blot using a rabbit serum specific for Net1
phosphorylated on Ser152 (pS152-Net1). B) HeLa cells, grown in 12-well
plate, were transfected with a HA-epitope tagged Net1A expression
plasmid (4 mg/well). Twenty-four hours after transfection, the cells were
left untreated (indicated as CTR), or: i) irradiated (20 Gy), and incubated
for the indicated time; ii) exposed to CDT (2 mg ml21) for 12h. The HA-
Net1A protein was immunoprecipitated using an a-HA antibody, and
the levels of Net1 phosphorylated on Ser152 (pS152-HA-Net1) were
assessed as in Figure 1A. The same membrane was re-probed with an a-
HA antibody (GA-Net1). The fold increase represents the ratio between
the levels of pS152-Net1 in treated cells and the levels of pS152-Net1 in
untreated cells (mean6SD of three independent experiments).
doi:10.1371/journal.pone.0002254.g001
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Figure 2. Net1 knock down prevents RhoA activation upon induction of DNA damage. HeLa cells were transfected with plasmids
expressing the control or Net1 specific shRNAs (panel A), or control or Net1 specific siRNA (panel B). Expression of the endogenous Net1 was
analysed by western blot 96h (A) or 72h (B) after transfection. Percentage inhibition was calculated as (1- residual Net1)6100, where residual Net1 is
defined as the ratio between the optical density of the Net1 specific band in cells transfected with the Net1 iRNA or control iRNA and the optical
density of the Net1 specific band in the non-transfected cells. C) HeLa cells, transfected with control or Net1 specific shRNA or shRNA, were left
untreated, or exposed to IR (20 Gy), CDT (2 mg ml21), or CNF-1 (1 mg ml21), respectively, and further incubated for 4h. Activation of RhoA was
assessed by RhoA specific G-LISATM (mean 6SD of 5 independent experiments for IR and CNF, mean6SD of 3 independent experiments for CDT).
Since the effects of transfection with specific Net1 shRNA or siRNA were similar, the data from all these experiments have been summarized together
and indicated as iRNA. The fold increase represents the ratio between the levels of GTP-bound RhoA in treated cells and the levels of GTP-bound
RhoA in untreated cells. According to the paired t test, the reduced RhoA activation in irradiated or intoxicated cells transfected with Net1 iRNA is
statistically significant, while the effect of iRNA on the CNF1-induced RhoA activation is not statistically significant. D) HeLa cells non-transfected or
transfected with control or Net1 specific siRNA were exposed to CNF1 (1 mg ml21) for 6h. The actin cytoskeleton was visualized by TRITC-phalloidin
staining. The values represent the percentage of cells with stress fibers. Cells exhibiting more than 5 stress fibers were scored as positive.
doi:10.1371/journal.pone.0002254.g002
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or cells transfected with non-silencing siRNA or shRNA. In
contrast, knock down of endogenous Net1 expression prior to
intoxication resulted in significant reduction in the number of cells
presenting actin stress fibers (Figures 3A and 3B). This effect was
quantified by measuring the intensity of the phalloidin staining
using the ImageJ software. A significant decrease in the intensity of
fluorescence induced by intoxication was demonstrated in the
Net1 RNAi treated cells as compared to controls (Figure 3C).
Net1 regulates cell survival in response to DNA damage
Activation of RhoA promotes the survival of cells exposed to
CDT [6]. In order to investigate whether Net1 is required for this
RhoA mediated response, Net1 expression was inhibited by RNAi
prior to intoxication and cell death was assessed by monitoring
chromatin condensation. Down-regulation of Net1 resulted in a 4-
to 5-fold increase in the number of cells presenting chromatin
condensation 48h after intoxication (Figure 4A). Similar results
were obtained in cells expressing the dominant negative Net1DDH
(data not shown). Induction of cell death upon Net1 knock down
was confirmed by cleavage of the caspase-3 substrate PARP, as
detected by western-blot analysis (Figure 4B), and activation of the
pro-apoptotic protein Bax, as detected by immunostaining using
the conformation-dependent antibody 6A7 (Figures 4C and 4D).
The effect was already observed after 24h and became highly
significant within 48h of treatment. The late occurrence of CDT-
induced cell death observed upon Net1 knock down was similar to
that observed in cells expressing a dominant negative RhoA
(RhoAN19) [6]. These results indicate that Net1 is an essential
component in the survival response to DNA damage.
Net1/RhoA-dependent activation of p38 MAPK is
required for cell survival in intoxicated or irradiated cells
DNA damage was shown to induce activation of p38 MAPK
[17]. We therefore tested whether exposure of HeLa cells to CDT
or IR stimulates p38 MAPK activity, and whether this is required
for protection from cell death. Both CDT intoxication and
irradiation induced activation of p38 MAPK within 3h after
treatment and this effect was maintained for at least 24h, as
assessed by western blot using a p38 MAPK phospho-specific
antibody (p-p38) (Figure 5A). The kinetics of p38 MAPK
phosphorylation is in line with the previously reported kinetics of
RhoA activation, which peaks at 4h after exposure to CDT or IR
Figure 3. Net1 knock down prevents actin stress fiber formation upon intoxication. A) HeLa cells non-transfected, or transfected with
control or Net1 specific shRNA or siRNA, were left untreated or treated with CDT (2 mg ml21) for 24h. The actin cytoskeleton was visualized by TRITC-
phalloidin staining (red). B) Quantification of cells with actin stress fibers (mean6SD of 5 independent experiments: three performed with shRNA and
two performed with siRNA). One hundred and fifty cells were counted for each experiment. Cells carrying more than 5 stress fibers were scored as
positive. C) The fluorescence intensity per each cell was quantified using the ImageJ software. Data are presented as ratio between the mean
fluorescence intensity and the cell area. iRNA is defined as in Figure 2B.
doi:10.1371/journal.pone.0002254.g003
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[6]. To determine whether p38 MAPK activation is important for
cell survival, the cells were treated with the p38 MAPK specific
inhibitors SB203580 or SB202190 (20 mM) prior to irradiation or
intoxication. Inhibition of p38 MAPK was associated with a 2- to
4-fold increase in the number of cells exhibiting chromatin
condensation 48h after treatment (Figure 5B and data not shown).
The increased rate of cell death was confirmed by monitoring
activation and increased expression of Bax (Figures 5C and 5D).
Activation of p38 MAPK in response to DNA damage was also
observed in the colorectal carcinoma cell line HCT116 upon
irradiation (Figure 6A). As in HeLa cells, pre-treatment of
HCT116 cells with SB203580 prior to irradiation was associated
with increased activation of Bax (Figure 6B). Quantification of the
Bax positive cells in this set of experiments was hampered by the
low number of cells that survived irradiation upon pre-treatment
with SB203580 (Figure 6C). These results indicate that activation
of p38 MAPK protects the cells from death induced by DNA
damage.
To assess whether the activation of p38 MAPK was dependent
on RhoA and its regulator Net1, the levels of irradiation-induced
phosphorylation were assessed in cells where the expression of the
two proteins was independently knocked down by RNAi.
Transfection with two independent RhoA specific siRNA
oligonucleotides consistently induced a 70 to 80 percent reduction
of the endogenous levels of RhoA (Figure 7A), and this effect was
associated with a strong inhibition of p38 MAPK activation in
response to IR and CDT (Figures 7B and 7C). Similar levels of
inhibition were obtained by blocking RhoA activity using the cell
Figure 4. Net1 knock down increases the rate of cell death upon induction of DNA damage. HeLa cells were transfected with control or
Net1 specific shRNA or siRNA and exposed to CDT (2 mg ml21) for 48h. Cell death was assessed by quantifying the percentage of cells presenting
chromatin condensation by Hoechst 33258 staining (panel A), detection of the cleaved form of PARP (PARP*) by western-blot (panel B) and detection
of activated Bax, using the anti-Bax 6A7 antibody (red; panel C). D) Quantification of the Bax positive cells (mean6SD of 5 independent experiments:
three performed with siRNA and two performed with shRNA). iRNA is defined as in Figure 2B. According to the t test, the increased number of cells
expressing the activated form of Bax upon transfection with Net1 specific iRNA is statistically significant both at 24h and 48h after intoxication.
doi:10.1371/journal.pone.0002254.g004
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Figure 5. p38 MAPK regulates cell survival in response to DNA damage. A) HeLa cells were: i) left untreated; ii) exposed to CDT (2 mg ml21)
for the indicated time periods; iii) irradiated (20 Gy) and further incubated in complete medium for the indicated time periods. Samples were
subjected to western blot analysis using a a-p38 antibody (p38*) or a p38 phospho-specific antibody (p-p38). B) HeLa cells, pre-treated with the
specific p38 MAPK inhibitor SB203580 (20 mM) in complete medium for 30 min, were left untreated, or irradiated (20 Gy) and further incubated for
48h. Cell death was assessed by quantifying the number of cells presenting chromatin condensation by Hoechst 33258 staining. C) HeLa cells were
treated as described in Figure 5B, and the activated form of Bax was detected by indirect immunofluorescence using the anti-Bax 6A7 antibody
(upper panel). Nuclei were counterstained with Hoechst 33258 (lower panel). As a positive control for Bax staining the cells were treated with 50 ng/
ml TNFa and 100 mg/ml cyclohexmide in complete medium for 6h at 37uC. D) HeLa cells, pre-treated with the specific p38 MAPK inhibitor SB203580
(20 mM) in complete medium for 30 min, were left untreated, treated with CDT (2 mg ml21) for 48h, or irradiated (20 Gy) and further incubated for
48h. Expression of Bax was detected by western blot analysis using antibodies specific for Bax or actin. Fold increase represents the ratio between the
optical density of the Bax specific band in treated cells and optical density of the Bax specific band in the untreated cells.
doi:10.1371/journal.pone.0002254.g005
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permeable inhibitor C3 transferase (data not shown). Knock down
of endogenous Net1 expression, by either siRNA or shRNA,
resulted in an equally potent inhibition of p38 MAPK activation in
irradiated cells (Figures 8A and 8B). These results indicate that
Net1 and RhoA are upstream signals in the p38 MAPK activation
cascade in response to DNA damage.
To determine whether the RhoA activated kinases ROCKI and
ROCK II are required for p38 MAPK activation, HeLa cells were
treated with the ROCKI/II inhibitors H-1152 or Y27632 prior to
irradiation. As expected, pre-treatment of control HeLa cells with
both inhibitors altered the organization of the actin cytoskeleton
and prevented the formation of actin stress fibers upon irradiation
(Figure 9A), confirming that these effectors were efficiently
blocked. However, the treatment did not impair the activation
of p38 MAPK (Figure 9B), indicating that ROCKI/II were not
required for signalling to this kinase.
The MAPK-activated protein kinase 2 (MK2) is a direct
substrate of the p38 MAPK a-and b-isoforms [18]. We asked
Figure 6. DNA damage activates p38 MAPK in HCT116 cells. A) HCT116 cells were left untreated or irradiated (20 Gy) and further incubated in
complete medium for 3h. Samples were subjected to western blot analysis as described in Figure 5A. B) HCT116 cells, pre-treated with the specific
p38 MAPK inhibitor SB203580 (20 mM) in complete medium for 30 min, were left untreated or irradiated (20 Gy) and further incubated for 48h. Cell
death was assessed by detection of activated Bax, using the anti-Bax 6A7 antibody (upper panel). Nuclei were counterstained with Hoechst 33258
(lower panel). C) HCT116 cells, pre-treated with the specific p38 MAPK inhibitor SB203580 (20 mM) in complete medium for 30 min, were irradiated
(20 Gy) and further incubated for 48h. Cells were visualized by contrast phase microscopy.
doi:10.1371/journal.pone.0002254.g006
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therefore whether this protein is also activated in a Net1- and
RhoA-dependent manner upon induction of DNA damage. As
illustrated in Figure 10, a 2- to 4-fold increase in the
phosphorylation of MK2 on its activating site Thr334 (p-MK2)
was observed in HeLa cells 4h after irradiation or intoxication
(Figure 10A), and a similar effect was observed in irradiated
HCT116 cells (Figure 10B). As expected, this effect was prevented
by pre-treatment with the p38 MAPK specific inhibitor SB203580
(Figure 10A). Importantly, the phosphorylation of MK2 following
irradiation was abrogated by knock down of either Net1 or RhoA,
indicating that these proteins are required for MK2 activation
(Figures 10C and 10D).
Discussion
The transforming ability of a truncated form of Net1 described
by Chen et al. [12] suggests that this protein may be involved in
regulating the delicate balance between cell growth and cell death.
This possibility is substantiated by our finding that Net1 regulates
the activation of RhoA and p38 MAPK, and promotes cell
survival in response to genotoxic agents. Furthermore, our data
identify genotoxic stress as a trigger for Net1 activation and
contribute to the characterization of a novel DNA damage-
induced survival pathway involving Net1 and its downstream
targets RhoA and p38 MAPK.
Net1 is activated and regulates RhoA-dependent actin
stress fiber formation upon induction of DNA damage
Alberts et al. have previously shown that phosphorylation of Net1
on Ser152 prevents RhoA activation and concluded therefore that
pSer152 inhibits the GEF activity of Net1 [15]. We now show that
exposure to CDT or IR decreases the levels of pSer152
phosphorylation of the endogenous as well as an ectopically
expressed Net1 (Figure 1), thus identifying genotoxic stress as a
signal for Net1 activation in vivo. The mechanisms involved in Net1
de-phosphorylation remain unknown. A constitutively active form of
the Rac1-activated protein kinase PAK1 (PAK1*) was identified as
the Ser152-specific Net1 kinase in vitro, and expression of PAK1*
prevented Net1-induced stress fiber formation in Swiss 3T3 cells
[15]. We did not observe any significant change in the level of Rac1
or Cdc42 activation in HeLa cells or primary fibroblasts exposed to
CDT or IR [6], and PAK1 activity was not changed within 30 min
after irradiation, a time when the dephosphorylation of pS152-Net1
was maximal (data not shown). This suggests that the decrease in
pSer152-Net1 observed in our experiments does not involve
inactivation of PAK1. Conceivably, a different, as yet unknown
Net1 specific kinase may be down-regulated. Alternatively, exposure
to CDT or IR may enhance the rate of p-S152-Net1 de-
phosphorylation by activation of a phosphatase.
Inhibition of endogenous Net1 by RNAi and expression of a
dominant negative Net1 demonstrated that this GEF is required
for RhoA activation and for the subsequent re-organization of the
actin cytoskeleton in response to intoxication or irradiation
(Figures 2 and 3). It is noteworthy that stress fiber formation
is detected in epithelial cells that are arrested in G1 following
treatment with TGF-b [19–21], and similar changes occur in cells
exposed to bacterial toxins that inhibit, Cycle inhibiting factor (Cif)
[22], or promote, Pasteurella multocida toxin (PMT) [23], cell cycle
progression. Net1 is a major player in the morphological changes
that characterize both TGF-b [21] and DNA damage (in this
work). It is thereby tempting to speculate that Net1-regulated
cytoskeleton rearrangements may be a common feature of the
response to stress signals that deregulate the cell cycle.
Net1/RhoA-dependent survival signals
Our RNAi experiments demonstrate that Net1 and RhoA are
critical for protecting intoxicated and irradiated cells from cell
death induced by DNA damage (Figure 4), and identify p38
MAPK as a key mediator in the delivery of the survival signals
(Figures 5 to 9). The mechanism by which RhoA controls p38
MAPK phosphorylation remains still unclear. Marinissen at al.
demonstrated that RhoA stimulates c-jun expression via activation
of the p38c MAPK isoform, resulting in aberrant cell growth and
malignant transformation [24]. Interestingly, we have found that
Figure 7. DNA damage-induced p38 phosphorylation is RhoA-
dependent. A) HeLa cells were transfected with the control siRNA or
two independent RhoA specific siRNA (siRNA1: Hs_RHOA_6; siRNA2:
Hs_RHOA_7). Expression of the endogenous RhoA levels was analysed
by western blot. Percentage inhibition was calculated as in Figure 2A.
B) Untransfected HeLa cells or cells transfected with control siRNA, or
two independent RhoA specific siRNA were left untreated or irradiated
(20 Gy), and further incubated for 4h in complete medium. p38
phosphorylation was assessed as in Figure 5A. p-p38 ratio represents
the ratio between the optical density of the phospho-p38 band in
treated cells and optical density of the phospho-p38 band in the
untreated cells. C) Quantification of the changes in the levels of p38
phosphorylation in HeLa cells transfected with control siRNA, RhoA
specific siRNA1 or siRNA2. Mean6SD of 6 independent experiments
performed with cells exposed to IR (left panel), and 3 independent
experiments performed cells exposed to CDT (right panel) cells. p-p38
ratio is defined as in Figure 7B.
doi:10.1371/journal.pone.0002254.g007
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the activation of p38 MAPK in response to DNA damage was
abrogated by SB203580 and SB202190 that are specific inhibitors
for the a- and b-isoforms of p38 MAPK [25], suggesting that
different isoforms may be targeted by RhoA depending on the
triggering stimulus. A large number of effector proteins mediate
signalling downstream of RhoA [26]. Since the RhoA activated
kinases ROCKI and ROCKII regulate many of the cytoskeletal
effects of RhoA, we examined whether they transduced the signal
from RhoA to p38 MAPK. Interestingly, pre-treatment with
pharmacological inhibitors of ROCK did not prevent p38 MAPK
activation, but inhibited stress fiber formation (Figure 9),
suggesting that RhoA may utilize different sets of effector proteins
to control these cellular responses. This is likely to require the
selective clustering of the downstream effectors on distinct scaffold
proteins, as suggested by the finding that the RhoA-dependent
activation of JNK involves the association of Net1 and the JNK
activators MLK2, MLK3 and MKK7 with the scaffold protein
CNK1, while this is not required for induction of stress fibers [27].
The current literature identifies JNK as the main MAPK induced
by irradiation [17]. Consistent with our previous results showing that
CDT or IR do not activate the JNK regulators Rac and Cdc42 [6],
we detected only low levels of JNK phosphorylation and AP1
activation 4h and 12h after intoxication in HeLa cells (data not
shown). In contrast, up to 10 fold increase of p38 MAPK
phosphorylation was consistently observed both in HeLa and
HCT116 cells (Figures 5 and 6). This result is not surprising
since, depending on the experimental models, p38 MAPK was
shown to contribute to either survival or death signals in response to
DNA damage [17]. The downstream signals involved in the survival
response remain unclear. Reinhardt at al. recently showed that the
survival in p53-deficient fibroblasts exposed to cisplatin and
doxorubicin is enhanced by ATM-dependent activation of p38
MAPK and its downstream effector MK2 [28]. This pathway has
been defined as the third cell cycle-dependent checkpoint, in
addition to the well-characterized ATM/Chk2 and ATR/Chk1
responses [28]. Our findings demonstrate that these signals operate
also in tumor cells, such as HeLa and HCT116, since blockage of
p38 MAPK activation by specific inhibitor abrogates their capacity
to survive irradiation or intoxication (Figures 5 and 6).
Furthermore, we have identified Net1 and RhoA as key molecules
controlling the activation of this novel checkpoint pathway
(Figures 7 and 8). A schematic illustration of the Net1-regulated
signal cascade identified in this work is shown in Figure 11.
Conclusions
Any event capable of promoting the survival of cell with
damaged DNA is detrimental since it would favour tumor
initiation and/or progression (reviewed in [29,30]). Our finding
that induction of DNA damage by CDT is accompanied by the
concomitant activation of survival signals suggests that chronic
infection with CDT producing bacteria may promote genomic
instability and favour malignant transformation. The association
between bacterial infections and cancer is poorly understood. The
only bacterium classified as human carcinogen is Helicobacter pylori,
but a possible involvement in oncogenesis has been suggested for
other bacteria, such as for example the Gram-negative bacterium
Salmonella typhi [31]. Indeed, several Gram-negative bacteria have
been shown to produce DNA damaging toxins [32,33]. The work
Figure 8. DNA damage-induced p38 phosphorylation is Net1-dependent. A) Untransfected HeLa cells or cells transfected with either the
Net1 specific siRNA (left panel) or shRNA (right panel), or the relevant controls were left untreated or irradiated (20 Gy), and further incubated for 4h
in complete medium. p38 phosphorylation was assessed as in Figure 5A. B) Quantification of the changes in the levels of p38 phosphorylation in
irradiated HeLa cells transfected with control or Net1 specific iRNA. iRNA is defined as in Figure 2B. Mean6SD of 6 independent experiments (three
performed with siRNA, and three performed with shRNA).
doi:10.1371/journal.pone.0002254.g008
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described in this paper provides the first molecular characteriza-
tion of a survival pathway triggered by CDT intoxication. Further
dissection of this pathway will provide new tools to elucidate the
mechanisms of bacterial-induced carcinogenesis, and may also
help to design specific inhibitors that can act synergistically with
conventional chemotherapy.
Materials and Methods
Cell lines and plasmids
HeLa and HCT116 cell lines were obtained from the ATCC
and grown as described [6]. The plasmid expressing the c-Myc
epitope-tagged Net1DDH was a kind gift from Drs. A. Hall and A.
Schmidt (Medical Research Council Laboratory for Molecular
Cell Biology, University College London, London, UK). The
plasmid expressing the Net1A protein was previously described
[16].
CDT and treatments
Production of the H. ducreyi CdtA, CdtB and CdtC subunits and
reconstitution of the active holotoxin (here named as CDT) was
previously described [6,34].
CDT intoxication. Cells were incubated for the indicated
time periods with CDT (2 mg ml21) in complete medium.
Ionizing radiation. Cells were irradiated (20 Gy), washed
once with PBS and incubated for the indicated time periods in
complete medium.
SB203580/SB202190 treatment. Cells were pre-treated
with the p38 MAPK specific inhibitors SB203580 or SB202190
(20 mM) (Calbiochem) in complete medium for 30 min at 37uC,
before exposure to CDT or IR.
ROCK inhibitors. Cells were pre-treated with the ROCK
inhibitors H-1152 and Y27632 (10 mM) (Calbiochem) in complete
medium for 1h at 37uC, before exposure to CDT or IR, and then
further incubated in the presence of the inhibitor for the indicated
periods of time.
Immunofluorescence
Phalloidin staining. Phalloidin staining of actin filaments
was performed as previously described [6].
Bax 6A7 staining. Cells were fixed with 4% paraformaldehyde,
and permeabilized with 0.2% Triton X-100 for 2 min at 22uC.
Antibody non-specific binding was blocked with 3% BSA in PBS
for 30 min at 22uC. Slides were further incubated for 1h at 22uC
with the conformation-specific monoclonal antibody (6A7, BD
Pharmingen), which recognizes the activated form of Bax. Slides
were washed three times with PBS and then incubated with TRITC-
conjugated rabbit anti-mouse antibody (DAKO; diluted 1:100 in
Figure 9. ROCK inhibitors do not prevent DNA damage-induced p38 MAPK phosphorylation. A) HeLa cells, were left untreated or pre-
treated with the specific ROCK inhibitors H-1152 or Y27632 (10 mM) in complete medium for 1h prior to irradiation (20 Gy), and further incubated in
the presence or absence of the inhibitor for 12h. The actin cytoskeleton was visualized by FITC-phalloidin staining (green). B) HeLa cells, pre-treated
with the specific ROCK inhibitors H-1152 or Y27632 (10 mM) in complete medium for 1h, were left untreated or exposed to IR (20Gy), and further
incubated in the presence or absence of the inhibitors for the indicated periods of time. p38 MAPK phosphorylation was assessed as in Figure 5A.
doi:10.1371/journal.pone.0002254.g009
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PBS) for 30 min at 22uC. Nuclei were counterstained with Hoechst
33258 (Sigma; 0.5 mg ml21).
iRNA
Net1 shRNA. The following oligonucleotides were used for
production of Net1 specific shRNAs:
shRNA-A (target nucleotides: 312–332):
5 9 -TCTCAATCTCTCCTGTAAGAAATGGACAC-
CATTTCTTACAGGAGAGATTCT-39
59-CTGCAGAATCTCTCCTGTAAGAAATGGTCTC-
CATTTCTTACAGGAGAGATT-39
shRNA-B (targets nucleotides: 615–635):
59-TCTCAAAGTTGTCCATCATGTCAGAACATCTGA-
CATGATGGACAACTTCT-39
59-CTGCAGAAAGTTGTCCATCATGTCAGATGTTCT-
GACATGATGGACAACTTT-39
shRNA-C (targets nucleotides: 819–837):
59-TCTCCAAAGCTCTTCTTGATCAATTCAAGAGATT-
GATCAAGAAGAGCTTTGCT-39
59-CTGCAGCAAGCTCTTCTTGATCAATCTCTT-
GAATTGATCGSTCAAGAAGAGCTTTG-39
Non targeting shRNA (scrambled sequence from Dlg1):
59-TCTCGAGAATGCGAGGTCAAGTTCTTCCTGT-
CAAACTTGACCTCGCATTCTCCT-39
59-CTGCAGGAGAATGCGAGGTCAAGTTTGACAG-
GAACAACTTGACCTCGCATTCTC-39
Figure 10. The p38 MAPK effector MK2 is phosphorylated in a Net1- and RhoA-dependent manner in response to genotoxic agents.
A) Untreated HeLa cells, or cells pre-treated with the specific p38 MAPK inhibitor SB203580 (20 mM) in complete medium for 30 min, were exposed to
CDT (2 mg ml21) for 4h, or irradiated (20 Gy) and further incubated in complete medium for 4h. Samples were subjected to western blot analysis
using antibodies specific for phospho-MK2 (p-MK2) or actin. B) HCT116 cells were left untreated or irradiated (20 Gy) and further incubated in
complete medium for 3h. Samples were subjected to western blot analysis as described in Figure 10A. C) HeLa cells transfected with: i) control siRNA;
ii) Net1 specific siRNA (left panel); iii) the RhoA specific siRNA1 (right panel) were left untreated or irradiated (20 Gy), and further incubated for 4h in
complete medium. MK2 phosphorylation was assessed as in Figure 10A. p-MK2 ratio represents the ratio between the optical density of the phospho-
MK2 band in irradiated cells and optical density of the phospho-MK2 band in the untreated cells. D) Quantification of the changes in the levels of
MK2 phosphorylation in irradiated HeLa cells: mean of 3 independent experiments performed with the Net1 specific siRNA (left panel) and 2
independent experiment performed with the RhoA specific siRNA (right panel).
doi:10.1371/journal.pone.0002254.g010
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The oligonucleotides were annealed and ligated into the
pGENECLIP-puromycin vector (Promega) according to the
manufacturer’s instructions.
Efficient down-regulation of the endogenous Net1 levels
required co-transfection with the three Net1 specific shRNA
expressing plasmids.
siRNA. The Net1 specific siRNA (HP validated 1027400), two
RhoA specific siRNAs (Hs_RHOA_6 HP validated SI02654211,
and Hs_RHOA_7 HP validated SI02654267), and the Alexa Fluor
488-labelled control siRNA (AATTCTCCGAACGTGTCACGT,
1022076) were purchased from Qiagen.
Transfection
HA-Net1A. Two hundred thousand and one hundred
thousand HeLa cells per well were grown in 12-well plates, or
24-well plates, respectively in complete medium. Transfections
were performed with the indicated amount of the relevant plasmid
using the Lipofectamine 2000 Reagent (Life Technologies),
according to the manufacturer’s instructions. Twenty-four hours
after transfection, cells were either intoxicated or irradiated and
incubated for the indicated time periods.
shRNA. One million Hela cells were grown in 6 cm diameter
Petri dishes in complete medium, and transfected with the
indicated shRNA plasmids (2 mg ml21) using the Lipofectamine
2000 Reagent. Twenty-four hours after transfection, complete
medium supplemented with puromycin (10 mg ml21) was added
and cells were further incubated for 72h.
siRNA. One hundred thousand HeLa cells were grown in 12-
well plate in complete medium. Transfection was performed with
75 ng/well of the indicated siRNA with HiPerFect Reagent
(Qiagen), according to the manufacturer’s instructions, and cells
were further incubated for 72h.
RhoA activation
RhoA activation was assessed by the G-LISATM RhoA
Activation Assay Biochem KitTM (Cytoskeleton) according to the
manufacturer’s instructions.
Immunoprecipitation
Immunoprecipitations were performed as previously described
[15]. The endogenous Net1 protein was immunoprecipitated using
a goat a-Net1 specific antibody (Abcam).
Western blot analysis
The following antibodies were used: a-HA, a-Bax (B-9) (Santa
Cruz Biotechnology), a-phospho-Net1-Ser152 [15], a-Net1 spe-
cific rabbit serum, a-Net1 goat serum (Abcam), a-actin (Sigma), a-
phospho-p38, a-p38, a-phospho-MK2 (Thr334), a-RhoA (Cell
Signaling), and a-PARP (BD Biosciences). Blots were developed
with enhanced chemiluminescence, using the appropriate horse-
radish peroxidase-labelled secondary antibody, according to the
instructions of the manufacturer (GE Healthcare).
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